Acetylation of retinoblastoma-like protein-2 (Rbl2/p130): an additional check on cell proliferation?
Keywords:
Acetylation, Retinoblastoma, Rbl2/p130, tumor suppressor, PTM, cell cycle.Abstract
Pocket proteins are important regulator of cell cycle progression. The family includes three members namely: retinoblastoma protein (pRb/p105), the founding member of the family, retinoblastoma like protein-1 (Rb121/p107) and retinoblastoma like protein-2 (Rb12/p130). Pocket proteins exert their role by binding with the members of E2F family of transcription proteins, thus making them unavailable for transcription of gene required for the entry into S-phase of cell cycle. The Functional activity of pocket proteins is regulated by phosphorylation. Once phosphorylated, Rb-E2F complex is disrupted. The abrogation of Rb functions, leads to unchecked G1-S phase transition and uncontrolled cell division. The ultimate impact is tumor formation. Recently, we have demonstrated that Rbl2/p130 is also subject to posttranslational acetylation. The exact role of Rbl2/p130 acetylation in cell cycle control and tumor genesis remains elusive. This review discusses acetylation being a prerequisite for phosphorylation and investigates a possible role of Rbl2/p130 acetylation in regulating G1/S phase of cell cycle.
Downloads
Published
Issue
Section
License
OPEN ACCESS
All the articles of the European Journal of Oncology and Environmental Health are published with open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0 http://creativecommons.org/licenses/by/4.0/). This means that the author(s) retain copyright, but the content is free to download, distribute and adapt for commercial or non-commercial purposes, given appropriate attribution to the original article.
The articles in the previous edition of the Journal (European Journal of Oncology) are made available online with open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0 http://creativecommons.org/licenses/by/4.0/).
Upon submission, author(s) grant the Journal the license to publish their original unpublished work within one year, and the non exclusive right to display, store, copy and reuse the content. The CC-BY Creative Commons attribution license enables anyone to use the publication freely, given appropriate attribution to the author(s) and citing the Journal as the original publisher. The CC-BY Creative Commons attribution license does not apply to third-party materials that display a copyright notice to prohibit copying. Unless the third-party content is also subject to a CC-BY Creative Commons attribution license, or an equally permissive license, the author(s) must comply with any third-party copyright notices.